🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Silvio Danese

IRCCS Ospedale San Raffaele

ORCID: 0000-0001-7341-1351

Biochemistry, Genetics and Molecular BiologyImmunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 14 papers. Top paper: “Deep Remission at 1 Year Prevents Progression of Early Crohn’s Disease”.

Deep Remission at 1 Year Prevents Progression of Early Crohn’s Disease

Gastroenterology(2020)10.1053/j.gastro.2020.03.039

N/A

5.7DataRank · unranked

240 citations

Clara Yzet, Peter Bossuyt, Filip J. Baert, Thomas Vanasek, Geert D’Haens +34 more

Intestinal Host Response to SARS-CoV-2 Infection and COVID-19 Outcomes in Patients With Gastrointestinal Symptoms

Gastroenterology(2021)10.1053/j.gastro.2021.02.056

N/A

5.2DataRank · unranked

162 citations

Divya Jha, Francesca Cossarini, Ana S. Gonzalez‐Reiche, Minami Tokuyama, Teresa Aydillo +48 more

Upadacitinib Induction and Maintenance Therapy Improves Abdominal Pain, Bowel Urgency, and Fatigue in Patients With Ulcerative Colitis: A Post Hoc Analysis of Phase 3 Data

Inflammatory Bowel Diseases(2023)10.1093/ibd/izad016

N/A

0.761DataRank · unranked

25 citations

Jacinda Tran, Geert D’Haens, David T. Rubin, Nobuo Aoyama, Wen Zhou +5 more

Long-term efficacy and safety of upadacitinib in patients with moderately to severely active ulcerative colitis: an interim analysis of the phase 3 U-ACTIVATE long-term extension study

The Lancet. Gastroenterology & hepatology(2025)10.1016/s2468-1253(25)00017-2

N/A

0.690DataRank · unranked

22 citations

Séverine Vermeire, Silvio Danese, Peter Higgins, Gary R. Lichtenstein, Hiroshi Nakase +12 more

Gastrointestinal involvement attenuates COVID-19 severity and mortality

medRxiv(2020)10.1101/2020.09.07.20187666

N/A

0.568DataRank · unranked

43 citations

Divya Jha, Francesca Cossarini, Ana S. Gonzalez‐Reiche, Minami Tokuyama, Teresa Aydillo +38 more

Upadacitinib for Crohn’s Disease and Ulcerative Colitis Treatment: Hitting the Selective JAKpot

Gastroenterology(2021)10.1053/j.gastro.2020.04.034

N/A

0.494DataRank · unranked

26 citations

Ferdinando D’Amico, Silvio Danese, Tommaso Lorenzo Parigi

LIAISON® Calprotectin for the prediction of relapse in quiescent ulcerative colitis: The EuReCa study

United European Gastroenterology Journal(2022)10.1002/ueg2.12268

N/A

0.360DataRank · unranked

10 citations

Silvio Danese, Laurent Peyrin‐Biroulet, Miquel Sans, Fabrizio Bonelli, Mariella Calleri +5 more

The Risk of SARS-CoV-2 in Immunosuppressed IBD Patients

Crohn s & Colitis 360(2020)10.1093/crocol/otaa026

N/A

0DataRank · unranked

38 citations

Siew C. Ng, Silvio Danese, Krishna Rao, Peter Higgins

HLA-DP on Epithelial Cells Enables Tissue Damage by NKp44+ Natural Killer Cells in Ulcerative Colitis

Gastroenterology(2023)10.1053/j.gastro.2023.06.034

N/A

0DataRank · unranked

20 citations

Annika Niehrs, Frauke Degenhardt, Maria Schwerk, Ole Hinrichs, Ana Jordan-Paiz +94 more

Glucagon-like peptide 1 receptor is a T cell-negative costimulatory molecule

Cell Metabolism(2024)10.1016/j.cmet.2024.05.001

N/A

0DataRank · unranked

84 citations

Vera Usuelli, Sergio Dellepiane, Andy Joe Seelam, Teresa Vanessa Fiorentino, Francesca D’Addio +38 more

Fecal, Blood, and Urinary Biomarkers in Inflammatory Bowel Diseases

Journal of Translational Gastroenterology(2024)10.14218/jtg.2024.00017

N/A

0DataRank · unranked

18 citations

Ferdinando D’Amico, Alessandra Zilli, Tommaso Lorenzo Parigi, Mariangela Allocca, Gionata Fiorino +3 more

Long-Term Outcomes of the Excluded Rectum in Crohn’s Disease: A Multicenter International Study

Inflammatory Bowel Diseases(2022)10.1093/ibd/izac099

N/A

0DataRank · unranked

4 citations

Clara Yzet, N. Nair, Anketse Debebe, Alexa Rendon, Jean‐Frédéric Colombel +22 more

A Small CEACAM5 Peptide Restores the Protective Function of CD8+ Regulatory T Cells in Crohn’s Disease

Gastroenterology(2022)10.1053/j.gastro.2022.06.025

N/A

0DataRank · unranked

4 citations

Francesco Merlino, Carmen Correale, Zara Hovhannisyan, Ron Couri, Stefania Vetrano +6 more

Therapeutic drug monitoring of biologics in inflammatory bowel disease: unmet needs and future perspectives

The Lancet. Gastroenterology & hepatology(2022)10.1016/s2468-1253(21)00223-5

N/A

0DataRank · unranked

156 citations

Waqqas Afif, David Drobne, Marla C Dubinsky, Marc Ferrante, Peter M Irving +17 more